• Schedule an Appointment

  • Find a Doctor

  • The RFH Mobile
    Healthcare App


Surgical Oncology

Dr. Marzi Godrej Mehta
Consultant & Section Co-ordinator
Surgical Oncology
MBBS, MS (Gen Surgery), DNB Surgical Oncology
Surgical Oncology, Prince Aly Khan Hospital, Mumbai; Thoracic Oncology, Tata Memorial Hospital, Mumbai; Minimally Invasive Thoracic Oncology, Australia, Robotic Thoracic Surgery (ORSI-Belgium)
14 years of national & international experience in Surgical Oncology including Thoracic Oncology
Contact details

Dr. Marzi Godrej Mehta is a Consultant Surgical Oncologist (Thoracic) at the department of Surgical Oncology at Sir H. N. Reliance Foundation Hospital and Research Centre.

Dr. Mehta is a gold medallist from Sardar Patel University (Gujarat) in MS (General Surgery); after which he has done DNB in Surgical Oncology. Dr. Mehta has several Fellowships in Thoracic and Onco Thoracic Surgery from national as well as international institutes of high repute like Tata Memorial Hospital, Royal Melbourne Hospital, Peter MacCallum Cancer Institute and Epworth Richmond Hospital. He is also trained in Robotic Thoracic Surgery from (ORSI- Belgium).

Dr. Mehta has trained on various procedures of Surgical Oncology since 2004, including last eight years in General Thoracic and Thoracic Surgical Oncology. He is trained in open and minimally invasive surgery in Thoracic and Thoracic oncology as well as in Robotic Thoracic procedures.

He has participated in various national as well as international workshops and presentations in multi-disciplinary meetings. He has several journal publications in his field of expertise to his credit and has participated in a few randomised trials including ‘Three field radical vs two field oesophagectomy – a prospective RCT’ and ‘Posterolateral thoracotomy versus Nerve Sparing Thoracotomy (PotNest)’.

Dr. Mehta is also part of several completed and on-going research projects in his field of interest like Role of Lesser resections in Early stage Lung cancer who are medically unfit; Negative Predictive value of EBUS in Mediastinal staging (Royal Melbourne Hospital); Mediastinoscopy vs PET CT scan concordance in identifying N2 nodes in NSCLC: A study of 100 cases (Co Principal Investigator – TMH); Role of Whole body DW MRI in management of NSCLC (TMH) and Evaluation of clinical and histopathological response to a neoadjuvant regimen of paclitaxel and platinum in squamous cell carcinoma of the oesophagus (Co Investigator – TMH).

Additional Speciality Interests:
  • Minimally Invasive Surgery for Oesophagus, Lung and Mediastinal Masses.
  • Robotic Thoracic Surgery for esophagus, Lung and Mediastinal Masses